On November 2, JD HEALTH rose 3.04% in Regular Trading, trading at HK$39.26, with turnover of HK$149 million.
The move was accompanied by broad strength in Hong Kong-listed healthcare e-commerce and large-cap technology names. In the same segment, ALI HEALTH rose 2.3% and PA GOODDOCTOR rose 1.47%, indicating a sector-linked rebound that supported JD HEALTH shares.
Fundamentally, the company previously reported first-half revenue of RMB409 billion, up 15.9% year on year, while Non-IFRS operating profit reached RMB35 billion, up 40.3%, with operating margin improving to 8.5%. Its latest monthly securities report also showed the share capital structure remained stable, with no material share issuance or buyback during the latest reported month.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments